Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529837 · ClinicalTrials.gov registry record
Ultrasound Assessment of DILAPAN-S
A clinical trial, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- 44
- Enrollment target
NCT04529837: Completed study, sponsored by Eastern Virginia Medical School.
NCT04529837 is a clinical trial that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04529837 has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The goal of this observational prospective study is to assess the change in Dilapan-S rod diameters using transvaginal ultrasound over a period of 12 hours in term women undergoing induction of labor.
Primary Outcome
Rod diameters of Dilapan-S rods were measured via transvaginal ultrasound at 3,6,8, and 12 hours after placement.
Interventions
- OTHER Gauze
- OTHER No gauze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-06-30 |
What the finished NCT04529837 record still lists
NCT04529837 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Gauze is the first listed.
NCT04529837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04529837 about?
NCT04529837 is a clinical study titled "Ultrasound Assessment of DILAPAN-S". The goal of this observational prospective study is to assess the change in Dilapan-S rod diameters using transvaginal ultrasound over a period of 12 hours in term women undergoing induction of labor.
What is the current status of trial NCT04529837?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2020-10-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04529837?
The interventions under investigation include: Gauze (OTHER), No gauze (OTHER).
Who is sponsoring clinical trial NCT04529837?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI